Regeneron Pharmaceuticals
REGN
REGN
1,172 hedge funds and large institutions have $75B invested in Regeneron Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 111 funds opening new positions, 397 increasing their positions, 445 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.4% less ownership
Funds ownership: 85.76% → 85.36% (-0.4%)
11% less repeat investments, than reductions
Existing positions increased: 397 | Existing positions reduced: 445
11% less call options, than puts
Call options by funds: $1.43B | Put options by funds: $1.61B
Holders
1,172
Holding in Top 10
29
Calls
$1.43B
Puts
$1.61B
Top Buyers
| 1 | +$696M | |
| 2 | +$551M | |
| 3 | +$73.2M | |
| 4 |
D.E. Shaw & Co
New York
|
+$68M |
| 5 |
ZIG
Zurich Insurance Group
Zurich,
Switzerland
|
+$65.3M |
Top Sellers
| 1 | -$467M | |
| 2 | -$365M | |
| 3 | -$259M | |
| 4 |
BlackRock
New York
|
-$173M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$136M |